Steve Farina

Steve is currently Executive Director, Business Development, Strategic Assessment in the Corporate Development group at Alexion. He has over 15 years of pharmaceutical CI, commercial assessment and product / corporate strategy experience, plus 12 years of molecular biology research experience in oncology, hematology, genomics/proteomics and gene therapy.